Outcome of therapy‐related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysis-Reference-Cited by-同舟云学术

Outcome of therapy‐related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysis

Published:2022-04-05 Issue:4 Volume:40 Page:752-762
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Itonaga Hidehiro¹,Kida Michiko²,Hamamura Atsushi³,Uchida Naoyuki⁴,Ozawa Yukiyasu⁵,Fukuda Takahiro⁶,Ueda Yasunori⁷,Kataoka Keisuke⁸⁹,Katayama Yuta¹⁰,Ota Shuichi¹¹,Matsuoka Ken‐ichi¹²,Kondo Tadakazu¹³^ORCID,Eto Tetsuya¹⁴,Kanda Junya¹⁵,Ichinohe Tatsuo¹⁶,Atsuta Yoshiko¹⁷¹⁸,Miyazaki Yasushi¹¹⁹,Ishiyama Ken²⁰

Affiliation:

1. Department of Hematology Nagasaki University Hospital Nagasaki Japan

2. Department of Hematology NTT Medical Center Tokyo Tokyo Japan

3. Hematology Division Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

4. Department of Hematology Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital Tokyo Japan

5. Department of Hematology Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital Nagoya Japan

6. Department of Haematopoietic Stem Cell Transplantation National Cancer Center Hospital Tokyo Japan

7. Department of Hematology/Oncology and Transfusion and Hemapheresis Center Kurashiki Central Hospital Okayama Japan

8. Department of Medicine Division of Hematology Keio University School of Medicine Tokyo Japan

9. Division of Molecular Oncology National Cancer Center Research Institute Tokyo Japan

10. Department of Hematology Hiroshima Red Cross Hospital & Atomic‐bomb Survivors Hospital Hiroshima Japan

11. Department of Hematology Sapporo Hokuyu Hospital Sapporo Japan

12. Department of Hematology and Oncology Okayama University Hospital Okayama Japan

13. Department of Hematology Kyoto University Hospital Kyoto Japan

14. Department of Hematology Hamanomachi Hospital Fukuoka Japan

15. Department of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan

16. Department of Hematology and Oncology Research Institute for Radiation Biology and Medicine Hiroshima University Hiroshima Japan

17. Japanese Data Center for Hematopoietic Cell Transplantation Nagoya Japan

18. Department of Registry Science for Transplant and Cellular Therapy Aichi Medical University School of Medicine Nagoya Japan

19. Department of Hematology Atomic Bomb Disease and Hibakusha Medicine Unit Atomic Bomb Disease Institute Nagasaki University Nagasaki Japan

20. Department of Hematology Kanazawa University Hospital Kanazawa Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2991

Reference52 articles.

1. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

2. Cytogenetics, Not Just Previous Therapy, Determines the Course of Therapy-Related Myeloid Neoplasms

3. The evolving challenge of therapy-related myeloid neoplasms

4. Therapy-related myeloid neoplasms

5. International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: Overview report

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical outcomes of haploidentical stem cell transplantation (haplo-HSCT) for patients with therapy-related myelodysplastic syndrome: comparable to de novo myelodysplastic syndrome;Clinical and Experimental Medicine;2024-02-08

2. Therapy-related myelodysplastic syndromes in the genomics era;Bulletin du Cancer;2023-11

3. Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical relatives in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukemia: a propensity score analysis of a nationwide database;Annals of Hematology;2023-03-15

4. Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the American Society for Transplantation and Cellular Therapy Committee on Practice Guidelines;Transplantation and Cellular Therapy;2023-02

5. Allogeneic stem cell transplantation for patients with myelodysplastic syndromes;American Journal of Hematology;2022-10-28